Snapshot from Jun 28, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Roche / UBS

Roche & UBS

1 shared events · Importance 3 · Last updated Jun 14, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
14
Business
Tech-Led Market Rebound, Iran-Israel Ceasefire
Roche: Roche agreed to pay Nurix Therapeutics up to $2.3 billion for rights to an experimental blood-cancer drug.
UBS: UBS analysts raised their price target for Micron Technology, contributing to the stock's significant advance.
May 20, 2026 · 72 articles
NEWSDESK
Explore this relationship live

Track how Roche and UBS interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.